Having trouble accessing articles? Reset your cache.

Inspire, Allergan deal

The companies mutually terminated Inspire's rights and obligations to co-promote dry eye treatment Restasis cyclosporine under a 2001 deal with Allergan for Restasis and Prolacria diquafosol tetrasodium. Inspire remains eligible for worldwide royalties through

Read the full 344 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE